Urinary proteomic analysis of chronic allograft nephropathy
- 作者Edmond O'Riordan; Tatyana N. Orlova; Natalia Mendelev; Daniel Patschan; Rowena Kemp; Praveen N. Chander; Rena Hu; Gang Hao; Steven S. Gross; Renato V. Iozzo; Veronica Delaney; Michael S. Goligorsky
- 卷第2卷
- 印刷ISSN1862-8346
- 电子ISSN1862-8354
- 文件大小463.63KB
- 发表时间2008
- DOI10.1002/prca.200780137
- 页码1025-1035
Glycolytic enzyme inhibitors in cancer treatmentScatena, Roberto; Bottoni, Patrizia; Pontoglio, Alessandro; Mastrototaro, Lucia; Giardina, Bruno · Expert Opinion on Investigational Drugs · 2008
Cancer stem cells: the development of new cancer therapeuticsScatena, Roberto; Bottoni, Patrizia; Pontoglio, Alessandro; Giardina, Bruno · Expert Opinion on Biological Therapy · 2011
An update on pharmacological approaches to neurodegenerative diseasesScatena, Roberto; Martorana, Giuseppe E; Bottoni, Patrizia; Botta, Giorgia; Pastore, Paola; Giardina, Bruno · Expert Opinion on Investigational Drugs · 2007
Mitochondrial Dysfunction by Synthetic Ligands of Peroxisome Proliferator Activated Receptors (PPARs)Roberto Scatena; Giuseppe Martorana; Patrizia Bottoni; Bruno Giardina · 2004
[Advances in Experimental Medicine and Biology] Advances in Mitochondrial Medicine Volume 942 ||Scatena, Roberto; Bottoni, Patrizia; Giardina, Bruno · 2012
Mitochondria, ciglitazone and liver: A neglected interaction in biochemical pharmacologyRoberto Scatena; Patrizia Bottoni; Giuseppe E. Martorana; Federica Vincenzoni; Giorgia Botta; Paola Pastore; Bruno Giardina · 2007
Nitric oxide donor drugs: an update on pathophysiology and therapeutic potentialScatena, Roberto; Bottoni, Patrizia; Martorana, Giuseppe E; Giardina, Bruno · Expert Opinion on Investigational Drugs · 2005
Mitochondria, PPARs, and Cancer: Is Receptor-Independent Action of PPAR Agonists a Key?Scatena, Roberto; Bottoni, Patrizia; Giardina, Bruno · PPAR Research · 2008